Merck Life Science India ink MoU with GeNext Genomics
Biotech

Merck Life Science India ink MoU with GeNext Genomics

Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem

  • By IPP Bureau | November 22, 2024

Merck Life Science in India recently signed a Memorandum of Understanding (MoU) with GeNext Genomics Pvt Ltd, an emerging biotech company.

The MoU was signed between Aditya Sharma, Dr. Ashwin kashikar, Managing Director, Genext Genomics Pvt. Ltd; in the presence of Supriya Kashikar, Founder & CEO, GeNext Genomics Pvt Ltd and Ravi Kashikar, Chairman and Founder of Ankur Seeds.

This collaboration creates a unique competitive edge by combining local expertise with global biomanufacturing capabilities. By partnering with Merck for their world-class expertise in biomanufacturing, Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem.

Upcoming E-conference

Other Related stories

Startup

Digitization